H1N1 News
Most Popular H1N1 Story
AstraZeneca gets blockbuster return on MedImmune
Anyone who still thinks that AstraZeneca paid too much when it offered a hefty premium for MedImmune's shares should check out a new report from Jefferies International, which estimates that the Read more...
Latest Headlines
- August 20, 2010
- November 25, 2009
- September 11, 2009
- September 1, 2009
- August 20, 2009
- August 7, 2009
- July 16, 2009
- July 15, 2009
- June 29, 2009
- June 8, 2009
- June 5, 2009
- May 4, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
